Extrapancreatic effects of incretin hormones: evidence for weight‐independent changes in morphological aspects and oxidative status in insulin‐sensitive organs of the obese nondiabetic Zucker rat (ZFR)

Incretin‐based therapies are widely used to treat type 2 diabetes. Although hypoglycemic actions of incretins are mostly due to their insulinotropic/glucagonostatic effects, they may also influence extrapancreatic metabolism. We administered exendin‐4 (Ex‐4), a long‐acting glucagon‐like peptide rece...

Descripción completa

Detalles Bibliográficos
Autores principales: Colin, Ides M., Colin, Henri, Dufour, Ines, Gielen, Charles‐Edouard, Many, Marie‐Christine, Saey, Jean, Knoops, Bernard, Gérard, Anne‐Catherine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4985551/
https://www.ncbi.nlm.nih.gov/pubmed/27511983
http://dx.doi.org/10.14814/phy2.12886

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4985551/
https://www.ncbi.nlm.nih.gov/pubmed/27511983
http://dx.doi.org/10.14814/phy2.12886

Ejemplares similares